BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:11 PM
 | 
Feb 03, 2009
 |  BC Extra  |  Company News

FDA panel backs Effient

FDA's Cardiovascular and Renal Drugs Advisory Committee voted 9-0 on Tuesday to recommend approval of Effient prasugrel from Daiichi Sankyo (Tokyo:4568; Osaka:4568) and Eli Lilly (NYSE:LLY) to treat acute coronary...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >